Market closedNon-fractional
LeMaitre Vascular/LMAT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About LeMaitre Vascular
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.
Ticker
LMAT
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Burlington, United States
Employees
622
Website
www.lemaitre.com
LMAT Metrics
BasicAdvanced
$1.9B
Market cap
57.12
P/E ratio
$1.51
EPS
0.88
Beta
$0.58
Dividend rate
0.67%
Dividend yield
Price and volume
Market cap
$1.9B
Beta
0.88
Dividend rate
$0.58
Financial strength
Current ratio
7.57
Quick ratio
5.167
Long term debt to equity
5.301
Total debt to equity
6.121
Dividend payout ratio (TTM)
38.11%
Management effectiveness
Return on assets (TTM)
7.64%
Return on equity (TTM)
11.65%
Valuation
Price to earnings (TTM)
57.124
Price to revenue (TTM)
9.613
Price to book
6.4
Price to tangible book (TTM)
9.76
Price to free cash flow (TTM)
58.159
Dividend yield (TTM)
0.67%
Growth
Revenue change (TTM)
18.16%
Earnings per share change (TTM)
62.28%
3-year revenue growth (CAGR)
14.06%
3-year earnings per share growth (CAGR)
9.19%
3-year dividend per share growth (CAGR)
13.66%
What the Analysts think about LMAT
Analyst Ratings
Majority rating from 9 analysts.
LMAT Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$53M
9.43%
Net income
$9.8M
16.67%
Profit margin
18.35%
6.62%
LMAT Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.36
$0.33
$0.38
$0.44
-
Expected
$0.32
$0.30
$0.36
$0.39
$0.47
Surprise
13.77%
9.09%
6.38%
13.62%
-
LMAT News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for LeMaitre Vascular stock?
LeMaitre Vascular (LMAT) has a market cap of $1.9B as of July 27, 2024.
What is the P/E ratio for LeMaitre Vascular stock?
The price to earnings (P/E) ratio for LeMaitre Vascular (LMAT) stock is 57.12 as of July 27, 2024.
Does LeMaitre Vascular stock pay dividends?
Yes, the LeMaitre Vascular (LMAT) stock pays dividends to shareholders. As of July 27, 2024, the dividend rate is $0.58 and the yield is 0.67%. LeMaitre Vascular has a payout ratio of 38.11% on a trailing twelve-month basis.
When is the next LeMaitre Vascular dividend payment date?
The next LeMaitre Vascular (LMAT) dividend payment date is unconfirmed.
What is the beta indicator for LeMaitre Vascular?
LeMaitre Vascular (LMAT) has a beta rating of 0.88. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell LeMaitre Vascular stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.